Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...

Recursion Pharmaceuticals, Inc ( (RXRX)) has held its Q4 earnings call. Read on for the main highlights of the call.

Costumed beasts and creepy crawlies aren’t limited to Halloween. This week a wild and woolly band of bloodthirsty space ...

In the last few years, Chinese AI startup MiniMax has become one of the most exciting in the crowded global AI marketplace, ...

Elon Musk’s xAI has brought on board Indian-origin developer Aman Gottumukkala, the founder of Firebender, as part of its ...

Curated By Zoie Yung, The Programme Unfolds Through Installation, Moving-Image, Performance, And On-Site Dialogues ...

Gottumukkala is best known as the co-founder of Firebender, an AI coding assistant designed for Android developers.

Director Corey Andrew Barr explains why the upcoming edition will be the fair’s boldest, most forward-looking chapter yet.